Stockscreener 앱 받기
5.2253
6.76%
-0.3747
전일 마감가:
$5.60
열려 있는:
$5.51
하루 거래량:
1.23M
Relative Volume:
0.88
시가총액:
$725.14M
수익:
$62.04M
순이익/손실:
$-533.34M
주가수익비율:
-1.333
EPS:
-3.92
순현금흐름:
$-473.07M
1주 성능:
-18.79%
1개월 성능:
-8.87%
6개월 성능:
-15.23%
1년 성능:
-44.27%
1일 변동 폭
$5.20
$5.52
1주일 범위
$5.20
$6.50
52주 변동 폭
$4.155
$14.45
비르 바이오테크 Stock (VIR) Company Profile
명칭
Vir Biotechnology Inc
전화
415-906-4324
주소
1800 OWENS STREET, SAN FRANCISCO, CA
VIR을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
VIR
Vir Biotechnology Inc
|
5.22 | 777.93M | 62.04M | -533.34M | -473.07M | -3.92 |
|
VRTX
Vertex Pharmaceuticals Inc
|
421.69 | 109.22B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
629.03 | 67.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
422.96 | 57.35B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
830.90 | 50.87B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
182.67 | 39.72B | 447.02M | -1.18B | -868.57M | -6.1812 |
비르 바이오테크 Stock (VIR) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-09-03 | 개시 | Evercore ISI | Outperform |
| 2025-08-27 | 업그레이드 | BofA Securities | Neutral → Buy |
| 2024-01-29 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2023-09-08 | 다운그레이드 | BofA Securities | Buy → Neutral |
| 2023-03-06 | 업그레이드 | JP Morgan | Neutral → Overweight |
| 2023-02-21 | 업그레이드 | Goldman | Neutral → Buy |
| 2023-01-27 | 업그레이드 | Morgan Stanley | Underweight → Equal-Weight |
| 2022-09-14 | 개시 | SVB Leerink | Outperform |
| 2022-09-09 | 개시 | Morgan Stanley | Underweight |
| 2022-03-03 | 업그레이드 | Robert W. Baird | Underperform → Neutral |
| 2021-12-21 | 다운그레이드 | Robert W. Baird | Neutral → Underperform |
| 2021-10-25 | 업그레이드 | JP Morgan | Underweight → Neutral |
| 2021-09-22 | 다운그레이드 | Goldman | Buy → Neutral |
| 2021-06-04 | 재개 | Robert W. Baird | Neutral |
| 2021-01-27 | 다운그레이드 | JP Morgan | Neutral → Underweight |
| 2021-01-20 | 재확인 | H.C. Wainwright | Buy |
| 2020-10-05 | 개시 | BofA Securities | Buy |
| 2020-09-14 | 업그레이드 | Goldman | Neutral → Buy |
| 2020-09-11 | 업그레이드 | JP Morgan | Underweight → Neutral |
| 2020-08-20 | 개시 | Needham | Buy |
| 2020-03-19 | 다운그레이드 | JP Morgan | Neutral → Underweight |
| 2020-03-13 | 다운그레이드 | Goldman | Buy → Neutral |
| 2020-02-27 | 다운그레이드 | Robert W. Baird | Neutral → Underperform |
| 2020-02-04 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2019-11-14 | 개시 | Robert W. Baird | Neutral |
| 2019-11-05 | 개시 | Barclays | Overweight |
| 2019-11-05 | 개시 | Cowen | Outperform |
| 2019-11-05 | 개시 | Goldman | Buy |
| 2019-11-05 | 개시 | JP Morgan | Overweight |
모두보기
비르 바이오테크 주식(VIR)의 최신 뉴스
Insider Sell: Vicki Sato Sells 22,000 Shares of Vir Biotechnology Inc (VIR) - GuruFocus
Sato Vicki L, Vir Biotech director, sells $124k in VIR stock - Investing.com Canada
What the charts say about Vir Biotechnology Inc. todayJuly 2025 WrapUp & AI Enhanced Trading Signals - newser.com
Vir Biotechnology concludes Eclipse 1 Phase III trial enrolment for CHD - Yahoo
Is it too late to sell Vir Biotechnology Inc.2025 Market Trends & Fast Entry High Yield Stock Tips - newser.com
How Vir Biotechnology Inc. stock reacts to job market dataTrade Exit Summary & High Accuracy Trade Alerts - newser.com
What to do if you’re stuck in Vir Biotechnology Inc.Trade Risk Report & Target Return Focused Stock Picks - newser.com
How Vir Biotechnology Inc. stock reacts to oil pricesJuly 2025 Big Picture & AI Based Buy/Sell Signal Reports - newser.com
Vir Biotechnology Announces Completion of Enrollment in ECLIPSE 1 Phase 3 Trial for Chronic Hepatitis Delta - BioSpace
How to escape a deep drawdown in Vir Biotechnology Inc.July 2025 Patterns & Technical Entry and Exit Alerts - newser.com
Top chart patterns to watch in Vir Biotechnology Inc.Rate Cut & High Return Trade Opportunity Guides - newser.com
Why Vir Biotechnology Inc. stock is favored by top institutionsPortfolio Profit Report & Verified Swing Trading Watchlists - newser.com
Vir Biotechnology (VIR) Completes Enrollment for ECLIPSE 1 Trial - GuruFocus
Vir Biotechnology (NASDAQ: VIR) announces ECLIPSE 1 full enrollment; topline data Q1 2027 - Stock Titan
Tools to monitor Vir Biotechnology Inc. recovery probabilityJuly 2025 Analyst Calls & Expert Approved Momentum Ideas - newser.com
Vir Biotechnology Inc. stock trendline breakdownPortfolio Return Summary & Verified Momentum Stock Ideas - newser.com
Why Vir Biotechnology Inc. stock remains on watchlistsWeekly Volume Report & Weekly Market Pulse Updates - newser.com
How to manage a losing position in Vir Biotechnology Inc.2025 Analyst Calls & AI Driven Stock Reports - newser.com
Can technical indicators confirm Vir Biotechnology Inc.’s reversalIPO Watch & Expert Curated Trade Ideas - newser.com
Pattern recognition hints at Vir Biotechnology Inc. upside2025 Market Trends & Weekly Consistent Profit Watchlists - newser.com
Published on: 2025-11-03 02:05:03 - newser.com
Best data tools to analyze Vir Biotechnology Inc. stockForecast Cut & Real-Time Volume Spike Alerts - newser.com
Will Vir Biotechnology Inc. stock deliver consistent dividends2025 Biggest Moves & Free Safe Capital Growth Stock Tips - newser.com
Is now a turning point for Vir Biotechnology Inc.July 2025 Fed Impact & Community Consensus Picks - newser.com
Is Vir Biotechnology Inc. forming a reversal patternJuly 2025 Technicals & Real-Time Volume Triggers - newser.com
Vir Biotechnology, Inc. (VIR) Stock Forecasts - Yahoo Finance
Risk adjusted return profile for Vir Biotechnology Inc. analyzedQuarterly Portfolio Report & Safe Capital Growth Tips - newser.com
Vir Biotechnology Hits Day Low of $5.87 Amid Price Pressure - Markets Mojo
What analysts say about Vir Biotechnology Inc stockHigh Beta Stocks & Market Analysis Tools You Can Trust - earlytimes.in
Vir Biotechnology (NASDAQ:VIR) Major Shareholder Endurance (Cayman) Ltd Svf Sells 24,453 Shares - MarketBeat
Vir Biotechnology’s Phase 1 Study on VIR-5525: A Potential Game-Changer in Cancer Treatment? - MSN
How Vir Biotechnology Inc. stock reacts to inflationary pressuresWeekly Stock Report & Fast Gaining Stock Reports - newser.com
비르 바이오테크 (VIR) 재무 분석
매출
순이익
현금흐름
주당 순 이익
비르 바이오테크 주식 (VIR) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| SVF Endurance (Cayman) Ltd | 10% Owner |
Oct 28 '25 |
Sale |
6.50 |
24,453 |
159,006 |
14,574,083 |
| SVF Endurance (Cayman) Ltd | 10% Owner |
Oct 29 '25 |
Sale |
6.49 |
100 |
649 |
14,573,983 |
| SVF Endurance (Cayman) Ltd | 10% Owner |
Oct 27 '25 |
Sale |
6.05 |
66,403 |
401,585 |
14,598,536 |
| SVF Endurance (Cayman) Ltd | 10% Owner |
Oct 24 '25 |
Sale |
5.96 |
46,696 |
278,285 |
14,664,939 |
| SVF Endurance (Cayman) Ltd | 10% Owner |
Oct 23 '25 |
Sale |
5.99 |
154,383 |
924,723 |
14,711,635 |
| SVF Endurance (Cayman) Ltd | 10% Owner |
Oct 22 '25 |
Sale |
6.15 |
144,266 |
887,654 |
14,866,018 |
| SVF Endurance (Cayman) Ltd | 10% Owner |
Oct 20 '25 |
Sale |
6.20 |
220,535 |
1,367,273 |
15,119,959 |
| SVF Endurance (Cayman) Ltd | 10% Owner |
Oct 21 '25 |
Sale |
6.30 |
109,675 |
690,974 |
15,010,284 |
1.29%
0.56%
자본화:
|
볼륨(24시간):